Volagidemab (Anti-GCGR)
Volagidemab (Anti-GCGR) is an antagonistic monoclonal antibody (mAb) that targets glucagon receptor (GCGR). Volagidemab can be used in the research of type 1 diabetes (T1D). MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2487 |
Sku # | A2487-1mg*25 |
Pricing | 1mg*25, $5070.00 |